Comparison Table

Please rotate your device for details

  TruSight Myeloid AmpliSeq for Illumina Cancer Hotspot Panel v2
Key Use Somatic mutation detection in myeloid malignancies. Somatic analysis of hotspot regions in 50 cancer related genes.
Design Fixed set of probes that amplify 568 amplicons from tumor suppressor genes and mutational hotspots. Targets 54 full or partial genes associated with myeloid malignancies. Hotspot regions of 50 genes.
Library Prep Time 8 hours 5 hours
Genomic Content 141kb (568 amplicons, 54 genes) 22kb
Input Amount 50ng gDNA 10ng recommended
FFPE Compatible No Yes
Multiplexing Up to 96 plex Up to 96 plex
Method Amplicon Amplicon
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2026 Illumina, Inc. All rights reserved.